GENE ONLINE|News &
Opinion
Blog

Esophageal Squamous Cell Carcinoma
Innovent, Lilly’s PD-1 Inhibitor Approved to Treat Esophageal Cancer in China
2022-06-21
Lilly, Innovent’s Tyvyt Registers Positive Outcomes in Esophageal and Gastric Cancer Trials
2021-09-17
FDA Accepts BeiGene’s BLA for Esophageal Cancer Drug
2021-09-14
BeiGene’s Immunotherapy Drug Shines in Phase ESCC Trial
2021-01-31
Keytruda Receives Two New Approvals in Japan
2020-08-30
LATEST
Company Presentations at BIO 2024 Inspire Partnering
2024-06-14
GV Regains Compliance with Nasdaq Minimum Bid Price Requirement
2024-06-13
ARPA-H Fast-Tracks Biotech Startups: Funding Insights from BIO 2024 Panel
2024-06-12
Gene Therapy Innovations and Financial Challenges for the Future of Medicine
2024-06-12
BIO Releases DEI Survey in Partnership with Korn Ferry
2024-06-11
Advancing Healthcare Accessibility and Sustainable Development
2024-06-11
New CRISPR Method Enables Gene Edits in Cockroaches and All Insects
2024-06-11
EVENT
Scroll to Top